SEC Form 4 · accession 0001493152-26-031944
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Waldman
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000719135
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2026 | M | 12,000 | $1.88 | A | 17,338 | I | By SLAT |
| Common StockF1 | Jun 30, 2026 | F | 5,024 | $4.49 | D | 12,314 | I | By SLAT |
| Common Stock | holding | — | — | — | 37,563 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1,F2 | $1.88 | Jun 30, 2026 | M | 12,000 | D | — | Jul 28, 2026 | Common Stock | 12,000 | 0 | I |
Explanation of responses
- F1Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
- F2On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.